Vincent J. Angotti - Dec 13, 2023 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (ACRX)

Role
Chief Executive Officer, Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Stock symbol
ACRX
Transactions as of
Dec 13, 2023
Transactions value $
$7,268
Form type
4
Date filed
12/14/2023, 08:11 AM
Previous filing
Sep 11, 2023
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Purchase $7.27K +10K +10.89% $0.73 102K Dec 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.7198 to $0.73 on December 13, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.